Manufacturing, latest filing in September 2026

AAON, Inc.

AAON, Inc. has 7 Schedule 13D or 13G filings on record since 2025-11-12. 1 holder's latest filing reports 5% or more of common stock. Each figure below is the holder's own, as filed, with the filing linked.

Swipe the table sideways to see every column.

Swipe the table sideways to see every column.

The latest filing identifies AAON, Inc. by CUSIP 000360206 and gives its principal executive office as 2425 South Yukon, Tulsa (SCHEDULE 13G/A, 2026-09-08).

Swipe the table sideways to see every column.

Swipe the table sideways to see every column.

Allurion Technologies, Inc.

Allurion Technologies, Inc. has 5 Schedule 13D or 13G filings on record since 2025-11-07. 1 holder's latest filing reports 5% or more of common stock, par value $0.0001 per share. Each figure below is the holder's own, as filed, with the filing linked.

Swipe the table sideways to see every column.

Swipe the table sideways to see every column.

The latest filing identifies Allurion Technologies, Inc. by CUSIP 02008G300 and gives its principal executive office as 11 Huron Drive, Natick, MA 01760 (SCHEDULE 13D/A, 2026-09-02).

Swipe the table sideways to see every column.

Swipe the table sideways to see every column.

BetterLife Pharma Inc.

BetterLife Pharma Inc. has 1 Schedule 13D or 13G filing on record since 2026-09-22. 1 holder's latest filing reports 5% or more of common shares, no par value per share. Each figure below is the holder's own, as filed, with the filing linked.

Swipe the table sideways to see every column.

Swipe the table sideways to see every column.

The latest filing identifies BetterLife Pharma Inc. by CUSIP 08772P202 and gives its principal executive office as 1275 West 6th Avenue, #300, Vancouver (SCHEDULE 13G, 2026-09-22).

Row 11 of each Reporting Person's cover page to this Schedule 13G sets forth the percentage of common shares of the Issuer beneficially owned by such Reporting Person and is incorporated by reference.RA Capital Management, L.P., SCHEDULE 13G, 2026-09-22

Swipe the table sideways to see every column.

biote Corp.

biote Corp. has 5 Schedule 13D or 13G filings on record since 2026-05-13. 2 holders' latest filing reports 5% or more of a. Each figure below is the holder's own, as filed, with the filing linked.

Swipe the table sideways to see every column.

Swipe the table sideways to see every column.

The latest filing identifies biote Corp. by CUSIP 090683103 and gives its principal executive office as 1875 W. WALNUT HILL LN #100, IRVING, TX 75038 (SCHEDULE 13G/A, 2026-09-18).

Swipe the table sideways to see every column.

Swipe the table sideways to see every column.

Cadre Holdings, Inc.

Cadre Holdings, Inc. has 11 Schedule 13D or 13G filings on record since 2025-08-06. 3 holders' latest filing reports 5% or more of common stock, par value $0.0001 per share. Each figure below is the holder's own, as filed, with the filing linked.

Swipe the table sideways to see every column.

Swipe the table sideways to see every column.

The latest filing identifies Cadre Holdings, Inc. by CUSIP 12763L105 and gives its principal executive office as 13386 International Pkwy, Jacksonville, FL 32218 (SCHEDULE 13D/A, 2026-09-30).

Swipe the table sideways to see every column.

Ciena Corporation

Ciena Corporation has 8 Schedule 13D or 13G filings on record since 2025-12-04. 4 holders' latest filing reports 5% or more of common stock, par value $0.01 per share. Each figure below is the holder's own, as filed, with the filing linked.

Swipe the table sideways to see every column.

Swipe the table sideways to see every column.

The latest filing identifies Ciena Corporation by CUSIP 171779309 and gives its principal executive office as 7035 Ridge Road, Hanover, MD 21076 (SCHEDULE 13G/A, 2026-09-03).

Swipe the table sideways to see every column.

Cricut, Inc.

Cricut, Inc. has 6 Schedule 13D or 13G filings on record since 2025-08-14. 4 holders' latest filing reports 5% or more of class a common stock, $0.001 par value. Each figure below is the holder's own, as filed, with the filing linked.

Swipe the table sideways to see every column.

Swipe the table sideways to see every column.

The latest filing identifies Cricut, Inc. by CUSIP 22658D100 and gives its principal executive office as 10855 South River Front Parkway, South Jordan, UT 84095 (SCHEDULE 13G, 2026-09-21).

Swipe the table sideways to see every column.

CV Sciences, Inc.

CV Sciences, Inc. has 1 Schedule 13D or 13G filing on record since 2026-09-09. 1 holder's latest filing reports 5% or more of common stock, $0.0001 par value per share. Each figure below is the holder's own, as filed, with the filing linked.

Swipe the table sideways to see every column.

Swipe the table sideways to see every column.

The latest filing identifies CV Sciences, Inc. by CUSIP 126654102 and gives its principal executive office as 9530 PADGETT STREET, SUITE 107, SAN DIEGO, CA 92126 (SCHEDULE 13G, 2026-09-09).

Swipe the table sideways to see every column.

Eltek Ltd

Eltek Ltd has 2 Schedule 13D or 13G filings on record since 2025-12-04. 1 holder's latest filing reports 5% or more of ordinary shares, nominal value nis 3.0 per share. Each figure below is the holder's own, as filed, with the filing linked.

Swipe the table sideways to see every column.

Swipe the table sideways to see every column.

The latest filing identifies Eltek Ltd by CUSIP M40184208 and gives its principal executive office as 20 Ben Zion Galis St., Petach-Tikva (SCHEDULE 13D/A, 2026-09-15).

Nistec Golan Ltd.

Nistec Golan and Mr. Nissan originally acquired the Shares for investment purposesItem 4 of the SCHEDULE 13D/A filed 2026-09-15

Swipe the table sideways to see every column.

Focus Universal Inc.

Focus Universal Inc. has 2 Schedule 13D or 13G filings on record since 2026-09-10. No holder's latest filing reports 5% or more. Each figure below is the holder's own, as filed, with the filing linked.

Swipe the table sideways to see every column.

Swipe the table sideways to see every column.

The latest filing identifies Focus Universal Inc. by CUSIP 34417J609 and gives its principal executive office as 1515 WEST CAMERON AVENUE, WEST COVINA, CA 91790 (SCHEDULE 13G/A, 2026-11-06).

Swipe the table sideways to see every column.

Swipe the table sideways to see every column.

Glucotrack, Inc.

Glucotrack, Inc. has 4 Schedule 13D or 13G filings on record since 2026-02-17. 1 holder's latest filing reports 5% or more of common stock. Each figure below is the holder's own, as filed, with the filing linked.

Swipe the table sideways to see every column.

Swipe the table sideways to see every column.

The latest filing identifies Glucotrack, Inc. by CUSIP 45824Q887 and gives its principal executive office as 301 RT 17 NORTH, SUITE 800, RUTHERFORD, NJ 07070 (SCHEDULE 13G, 2026-09-02).

Swipe the table sideways to see every column.

Swipe the table sideways to see every column.

GT Biopharma, Inc.

GT Biopharma, Inc. has 1 Schedule 13D or 13G filing on record since 2026-09-15. 1 holder's latest filing reports 5% or more of common stock, $0.001 par value per share. Each figure below is the holder's own, as filed, with the filing linked.

Swipe the table sideways to see every column.

Swipe the table sideways to see every column.

The latest filing identifies GT Biopharma, Inc. by CUSIP 36254L407 and gives its principal executive office as 505 Montgomery Street, 10th Floor, San Francisco, CA 94111 (SCHEDULE 13G, 2026-09-15).

Swipe the table sideways to see every column.

Swipe the table sideways to see every column.

JE Cleantech Holdings Limited

JE Cleantech Holdings Limited has 2 Schedule 13D or 13G filings on record since 2026-09-16. 1 holder's latest filing reports 5% or more of class a ordinary shares, par value $0.003. Each figure below is the holder's own, as filed, with the filing linked.

Swipe the table sideways to see every column.

Swipe the table sideways to see every column.

The latest filing identifies JE Cleantech Holdings Limited by CUSIP G50875205 and gives its principal executive office as 3 Woodlands Sector 1, Singapore (SCHEDULE 13D/A, 2026-09-16).

HONG Bee Yin

The Reporting Person holds the Class A Ordinary Shares of the Issuer for investment purposes.Item 4 of the SCHEDULE 13D/A filed 2026-09-16

Swipe the table sideways to see every column.

Leggett & Platt, Incorporated

Leggett & Platt, Incorporated has 11 Schedule 13D or 13G filings on record since 2025-07-17. 3 holders' latest filing reports 5% or more of common stock, par value $.01 per share. Each figure below is the holder's own, as filed, with the filing linked.

Swipe the table sideways to see every column.

Swipe the table sideways to see every column.

The latest filing identifies Leggett & Platt, Incorporated by CUSIP 524660107 and gives its principal executive office as 1 LEGGETT ROAD, CARTHAGE (SCHEDULE 13G/A, 2026-11-09).

Swipe the table sideways to see every column.

Swipe the table sideways to see every column.

Londian Wason New Energy Tech Inc.

Londian Wason New Energy Tech Inc. has 2 Schedule 13D or 13G filings on record since 2026-09-10. 2 holders' latest filing reports 5% or more of ordinary shares, par value $0.00001 per share. Each figure below is the holder's own, as filed, with the filing linked.

Swipe the table sideways to see every column.

Swipe the table sideways to see every column.

The latest filing identifies Londian Wason New Energy Tech Inc. by CUSIP 54179A109 and gives its principal executive office as TL-7A, SHENZHEN BAY PLAZA, NO. 2233 SOUTH KEYUAN RD, NANSHAN DIST., SHENZHEN (SCHEDULE 13G, 2026-11-09).

17.1, calculated based on 394,006,470 Ordinary Shares outstanding immediately after the offering.Sk Inc., SCHEDULE 13G, 2026-09-10

The response of the Reporting Person to Row (11) of the cover pages of this Statement are incorporated herein by reference.Mirae Asset Global Investments Co., Ltd., SCHEDULE 13G, 2026-11-09

Swipe the table sideways to see every column.

Swipe the table sideways to see every column.

Metagenomi Therapeutics, Inc.

Metagenomi Therapeutics, Inc. has 1 Schedule 13D or 13G filing on record since 2026-09-10. 1 holder's latest filing reports 5% or more of common stock, par value $0.0001 per share. Each figure below is the holder's own, as filed, with the filing linked.

Swipe the table sideways to see every column.

Swipe the table sideways to see every column.

The latest filing identifies Metagenomi Therapeutics, Inc. by CUSIP 59102M104 and gives its principal executive office as 5959 HORTON STREET, 7TH FLOOR, EMERYVILLE, CA 94608 (SCHEDULE 13G, 2026-09-10).

Swipe the table sideways to see every column.

Swipe the table sideways to see every column.

Miller Industries Inc

Miller Industries Inc has 7 Schedule 13D or 13G filings on record since 2025-07-16. 3 holders' latest filing reports 5% or more of common. Each figure below is the holder's own, as filed, with the filing linked.

Swipe the table sideways to see every column.

Swipe the table sideways to see every column.

The latest filing identifies Miller Industries Inc by CUSIP 600551204 and gives its principal executive office as 8503 HILLTOP DR, STE 100, OOLTEWAH, TN 37363 (SCHEDULE 13G/A, 2026-09-04).

Swipe the table sideways to see every column.

Nuran Wireless Inc.

Nuran Wireless Inc. has 7 Schedule 13D or 13G filings on record since 2026-07-16. 6 holders' latest filing reports 5% or more of common shares, no par value. Each figure below is the holder's own, as filed, with the filing linked.

Swipe the table sideways to see every column.

Swipe the table sideways to see every column.

The latest filing identifies Nuran Wireless Inc. by CUSIP 67059X304 and gives its principal executive office as 2150 CYRILLE-DUQUET STREET, SUITE 100, QUEBEC (SCHEDULE 13G/A, 2026-10-29).

Swipe the table sideways to see every column.

Nutra Pharma Corp

Nutra Pharma Corp has 1 Schedule 13D or 13G filing on record since 2026-09-01. 1 holder's latest filing reports 5% or more of series b preferred shares. Each figure below is the holder's own, as filed, with the filing linked.

Swipe the table sideways to see every column.

Swipe the table sideways to see every column.

The latest filing identifies Nutra Pharma Corp by CUSIP 67060U208 and gives its principal executive office as 6400 Park of Commerce Blvd, Suite 1B, Boca Raton, FL 33487 (SCHEDULE 13D, 2026-09-01).

Pure Raw Supplies, LLC

The Reporting Person acquired the Shares pursuant to a bona fide gift and not as part of any purchase transaction. The Reporting Person holds the Shares for investment purposes. The Reporting Person does not presently have any plans or proposals that relate to or would result in any of the actions described in clauses (a) through (j) of Item 4 of Schedule 13D.Item 4 of the SCHEDULE 13D filed 2026-09-01

Swipe the table sideways to see every column.

nVent Electric plc

nVent Electric plc has 3 Schedule 13D or 13G filings on record since 2026-03-26. 2 holders' latest filing reports 5% or more of common stock. Each figure below is the holder's own, as filed, with the filing linked.

Swipe the table sideways to see every column.

Swipe the table sideways to see every column.

The latest filing identifies nVent Electric plc by CUSIP G6700G107 and gives its principal executive office as The Mille, 1000 Great West Road, 8th Flo, London (SCHEDULE 13G/A, 2026-09-04).

Swipe the table sideways to see every column.

Swipe the table sideways to see every column.

Semtech Corporation

Semtech Corporation has 11 Schedule 13D or 13G filings on record since 2025-08-14. 3 holders' latest filing reports 5% or more of common stock. Each figure below is the holder's own, as filed, with the filing linked.

Swipe the table sideways to see every column.

Swipe the table sideways to see every column.

The latest filing identifies Semtech Corporation by CUSIP 816850101 and gives its principal executive office as 200 FLYNN ROAD, CAMARILLO, CA 93012-8790 (SCHEDULE 13G/A, 2026-09-04).

Swipe the table sideways to see every column.

Syntec Optics Holdings, Inc.

Syntec Optics Holdings, Inc. has 1 Schedule 13D or 13G filing on record since 2026-09-21. 1 holder's latest filing reports 5% or more of common stock, par value $0.0001 per share. Each figure below is the holder's own, as filed, with the filing linked.

Swipe the table sideways to see every column.

Swipe the table sideways to see every column.

The latest filing identifies Syntec Optics Holdings, Inc. by CUSIP 87169M105 and gives its principal executive office as 515 Lee Road, Rochester, NY 14606 (SCHEDULE 13D/A, 2026-09-21).

Al Kapoor

Item 4 of the Schedule 13D is hereby amended and restated as follows: This transaction involved the Reporting Person's gift of shares of Syntec Optics Holdings, Inc. Class A Common Stock to irrevocable trusts for which he does not exercise or share voting or investment control. The Reporting Person disclaims beneficial ownership of the securities held by the trust, and this report shall not be deemed an admission that the Reporting Person is the beneficial owner for the purposes of Section 16 or for any other purpose.Item 4 of the SCHEDULE 13D/A filed 2026-09-21

Swipe the table sideways to see every column.

Viatris Inc

Viatris Inc has 12 Schedule 13D or 13G filings on record since 2025-08-07. 4 holders' latest filing reports 5% or more of common stock. Each figure below is the holder's own, as filed, with the filing linked.

Layoffs on record: 1 filing or notice, latest 2026-02-26 (layoff filings and notices).

Swipe the table sideways to see every column.

Swipe the table sideways to see every column.

The latest filing identifies Viatris Inc by CUSIP 92556V106 and gives its principal executive office as 1000 MYLAN BOULEVARD, CANONSBURG, PA 15317 (SCHEDULE 13G/A, 2026-11-06).

Swipe the table sideways to see every column.

Swipe the table sideways to see every column.

Vicor Corp

Vicor Corp has 12 Schedule 13D or 13G filings on record since 2026-01-23. 2 holders' latest filing reports 5% or more of common stock. Each figure below is the holder's own, as filed, with the filing linked.

Swipe the table sideways to see every column.

Swipe the table sideways to see every column.

The latest filing identifies Vicor Corp by CUSIP 925815102 and gives its principal executive office as 25 FRONTAGE ROAD, ANDOVER, MA 01810 (SCHEDULE 13G/A, 2026-09-08).

Swipe the table sideways to see every column.

Vogenx, Inc.

Vogenx, Inc. has 1 Schedule 13D or 13G filing on record since 2026-09-08. 1 holder's latest filing reports 5% or more of common stock. Each figure below is the holder's own, as filed, with the filing linked.

Swipe the table sideways to see every column.

Swipe the table sideways to see every column.

The latest filing identifies Vogenx, Inc. by CUSIP 92859A106 and gives its principal executive office as 3901 BARRETT DRIVE, SUITE 300, RALEIGH, NC 27609 (SCHEDULE 13G, 2026-09-08).

Swipe the table sideways to see every column.

Swipe the table sideways to see every column.

Xenetic Biosciences, Inc.

Xenetic Biosciences, Inc. has 4 Schedule 13D or 13G filings on record since 2026-02-12. 1 holder's latest filing reports 5% or more of common stock, $0.001 par value per share. Each figure below is the holder's own, as filed, with the filing linked.

Swipe the table sideways to see every column.

Swipe the table sideways to see every column.

The latest filing identifies Xenetic Biosciences, Inc. by CUSIP 984015602 and gives its principal executive office as 945 CONCORD ST., FRAMINGHAM, MA 01701 (SCHEDULE 13G, 2026-09-18).

Swipe the table sideways to see every column.